case_images: PMC9326303_01
case_images: Chest computed tomographic (CT) images of a 66-year-old COVID-19 patient before and after QFPDD. Case 6: A 66-year-old male with severe COVID-19. Panel 2-(A): In both lungs, transmissibility was reduced, and ground-glass opacity and mesh shadows were observed mostly under the pleura and with interstitial involvement. Scattered patchy opacities were observed mainly in the lower lobe of both lungs, and scattered small nodules were present in both lungs. Panel 2-(B): After two courses of QFPDD in combination with conventional treatment, the scattered ground-glass, strip-like, and patchy opacities in both lungs were absorbed and reduced compared to that measured at admission. Panel 2-(C): Ground-glass opacity was further reduced in both lungs before discharge.
case_images: fphar-13-849598-g001.jpg
case_images: PMC9326303_01_fphar-13-849598-g001.jpg
case_images: F1
case_images: We compared chest CT images before and after taking QFPDD (Figure 1).
case_images: Detailed course of eight COVID-19 cases during hospitalization.
case_images: fphar-13-849598-g002.jpg
case_images: PMC9326303_01_fphar-13-849598-g002.jpg
case_images: F2
case_images: Duration of the major clinical symptom recovery in eight COVID-19 cases. Numbers indicate the days when the major clinical symptoms (asthma, anorexia, nasal obstruction, cough, fatigue, sore throat, and fever) were completely cured. The size of the circle is positively correlated with the number of days.
case_images: fphar-13-849598-g003.jpg
case_images: PMC9326303_01_fphar-13-849598-g003.jpg
case_images: F3